Scholars Central

Review articlePublished 22 Nov 2015

Implication of Quinazoline-4(3H)-ones in Medicinal Chemistry: A Brief Review

Authors: Bipransh Kumar Tiwary, Kiran Pradhan, Ashis Kumar Nanda, Ranadhir Chakraborty

1Omics Laboratory, Department of Biotechnology, University of North Bengal, Darjeeling, West Bengal, India; 2Department of Chemistry, St. Joseph’s College, PO-North Point, Darjeeling, India; 3Department of Chemistry, University of North Bengal, Darjeeling, West Bengal, India

Journal of Chemical Biology & Therapeutics

Volume 1 · Issue 1 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Quinazoline, a heterocyclic compound, has been extensively studied and used in certain specific biological activities. The quinazoline-4(3H)-one and its derivatives constitute an important class of fused heterocycles that are found in more than 200 naturally occurring alkaloids. With passage of time, newer and more complex variants of the quinazolinone structures are being discovered. The stability of the quinazolinone nucleus has inspired researchers to introduce many bioactive moieties to this nucleus to create new potential medicinal agents. With a view to explore the versatile lead molecule 4(3H)-quinazolinones, a series of novel 2-methyl-3-(1’3’4-thiadiazole-2- yl)-4-(3H) quinazolinones have been synthesized by reacting 2-amino-5-aryl/alkyl-1’3’4’-thiadiazoyl with 2-substituted benzoxazin-2-one. The designed compounds have shown antibacterial activity on Staphylococcus aureus, Bacillus subtilis and Escherichia coli. In the journey of a compound to be established as a lead and finally to a drug, the problem of solubility is a major challenge for medicinal chemists and formulation scientists. The present review has touched all these issues with a hope that some of the quinazoline derivative with sufficient bioavailability could help us to counter the menace of antibiotic resistance.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical Biology & Therapeutics
  • SubjectChemistry
  • BylineArticles whose byline prints “Bipransh Kumar Tiwary”
  • BylineArticles whose byline prints “Kiran Pradhan”
  • BylineArticles whose byline prints “Ashis Kumar Nanda”
  • BylineArticles whose byline prints “Ranadhir Chakraborty”